Skip to main content

Diagnostic options ยท UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00โ€“150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 196โ€“210 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-1682
Cystic Fibrosis Mutation Screening (CFTR Test

This test specifically identifies the presence or absence of the common CFTR ฮ”F508 mutation.

Peripheral blood 7โ€“8 days 800.00 AED
View
View test specifications and preparation
What it measures
["CFTR gene mutation (ฮ”F508)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions"]
Indications
["Carrier screening", "Family planning", "Diagnostic confirmation in suspected cases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21657-1 ICD-10: E84.9, Z13.228
Clinical summary
This test specifically identifies the presence or absence of the common CFTR ฮ”F508 mutation.
TEST-1678
Cytochrome P450 2C19 Genotyping (CYP2C19) Clopidogrel Resistance (*2,*3,*4,*10) Test

This test evaluates the genetic variants in the CYP2C19 gene that influence the metabolism of the antiplatelet drug clopidogrel.

Peripheral Whole Blood 7 Working Days (Expedited Available) 800.00 AED
View
View test specifications and preparation
What it measures
["CYP2C19 gene variants (*2, *3, *4, *10)", "Clopidogrel metabolism phenotype (Poor, Intermediate, Extensive)"]
Parameters
[]
Preparation
["No specific fasting required", "No need to stop current medications unless advised by your physician"]
Indications
["Patients prescribed clopidogrel", "Patients with cardiovascular risk factors", "Patients undergoing percutaneous coronary intervention (PCI)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 65737-8 ICD-10: Z13.81
Clinical summary
This test evaluates the genetic variants in the CYP2C19 gene that influence the metabolism of the antiplatelet drug clopidogrel.
TEST-947
Cytomegalovirus (CMV) Qualitative PCR Test

This diagnostic test evaluates the presence of active Cytomegalovirus (CMV) DNA in a patient's sample.

Blood, Plasma, Serum, Amniotic Fluid, Cord Blood 1โ€“2 days 600.00 AED
View
View test specifications and preparation
What it measures
["Active viral DNA replication", "Presence of CMV genetic material"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Diagnosis of active CMV infection", "Monitoring immunocompromised patients", "Prenatal screening", "Newborn screening", "Pre-surgical clearance", "Travel abroad requirements"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 20447-3 ICD-10: B25.9
Clinical summary
This diagnostic test evaluates the presence of active Cytomegalovirus (CMV) DNA in a patient's sample.
TEST-1665
Cytomegalovirus (CMV) Quantitative PCR Test

This diagnostic test evaluates the quantity of Cytomegalovirus (CMV) DNA present in a patient's sample.

Peripheral blood, Plasma, Serum, Amniotic fluid, Cord Blood 1โ€“2 business days (stat options available) 700.00 AED
View
View test specifications and preparation
What it measures
["Cytomegalovirus (CMV) DNA", "Viral Load Quantification"]
Parameters
[{"name": "CMV DNA Viral Load", "reference_range": "
Preparation
["No fasting required", "Inform phlebotomist of anticoagulant therapy", "Inform phlebotomist of recent immunoglobulin infusions (within 4 weeks)"]
Indications
["Monitoring immunocompromised patients", "Post-transplant monitoring", "Pregnancy risk stratification", "Diagnosis of active CMV infection/disease", "Assessment of antiviral therapy effectiveness"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 20578-0 ICD-10: B25.9
Clinical summary
This diagnostic test evaluates the quantity of Cytomegalovirus (CMV) DNA present in a patient's sample.
TEST-5782
DDHD2 Gene SPG54 Genetic Test

This test sequences the entire DDHD2 gene to diagnose hereditary spastic paraplegia type 54 (SPG54), a rare progressive neurological disorder.

Whole Blood or Dried Blood Spot (FTA Card) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DDHD2 gene sequence", "Pathogenic single nucleotide variants", "Small insertions or deletions"]
Parameters
[]
Preparation
[]
Indications
["Suspected hereditary spastic paraplegia type 54 (SPG54)", "Family history of SPG54"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94244-1 ICD-10: G11.4
Clinical summary
This test sequences the entire DDHD2 gene to diagnose hereditary spastic paraplegia type 54 (SPG54), a rare progressive neurological disorder.
TEST-215
ddRAD (Double Digest Restriction Site Associated DNA) Library Preparation Service Test

This test constructs reduced-representation DNA libraries for genomic analysis.

Peripheral Whole Blood (2โ€“4 mL in EDTA) or Extracted DNA 1 Week 20,000.00 AED
View
View test specifications and preparation
What it measures
["Single Nucleotide Polymorphisms (SNPs)", "Genotyping data"]
Parameters
[]
Preparation
[]
Indications
["Population genetics studies", "Cancer susceptibility research", "Pharmacogenomics research", "SNP discovery"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93584-1 ICD-10: Z13.89
Clinical summary
This test constructs reduced-representation DNA libraries for genomic analysis.
TEST-275
ddRAD Sequencing and Primary Analysis (96 Samples) Test

This test identifies genetic variants in targeted regions relevant to cancer predisposition and autoimmune diseases.

Whole Blood (EDTA tube, 4 mL) or Extracted DNA (โ‰ฅ200 ng, TE buffer) 8 weeks (from sample receipt to report delivery) 55,000.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number alterations (CNAs)", "Pathogenic mutations in cancer predisposition genes", "Genetic markers in autoimmune diseases"]
Parameters
[]
Preparation
["No special dietary or medication preparation required.", "Inform phlebotomist about anticoagulant medications.", "Notify lab if recent blood transfusion or bone marrow transplant (within 3 months)."]
Indications
["Cancer predisposition risk assessment", "Targeted therapy selection in oncology", "Genetic marker identification in autoimmune/autoinflammatory diseases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: Z13.89
Clinical summary
This test identifies genetic variants in targeted regions relevant to cancer predisposition and autoimmune diseases.
TEST-174
ddRAD Sequencing Primary Data Analysis (96 Samples) Test

This test evaluates genetic variations (SNPs and structural variants) across 96 samples using a reduced-representation sequencing method.

Peripheral whole blood (EDTA tube) or buccal swab (saliva) 4 weeks 20,000.00 AED
View
View test specifications and preparation
What it measures
["Single Nucleotide Polymorphisms (SNPs)", "Structural Variants", "Genetic Markers"]
Parameters
[]
Preparation
[]
Indications
["Population-scale SNP discovery", "Cancer susceptibility profiling", "Autoimmune disorder panels", "Research-grade genetic marker identification"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81267-3 ICD-10: Z13.89
Clinical summary
This test evaluates genetic variations (SNPs and structural variants) across 96 samples using a reduced-representation sequencing method.
TEST-1668
Deafness Gene Panel Test

This test evaluates over 100 genes associated with hereditary hearing loss using next-generation sequencing.

Peripheral blood (preferred); amniotic fluid or chorionic villi (prenatal diagnosis โ€“ hospital-only collection) 4โ€“6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants", "Likely pathogenic variants", "Copy-number changes"]
Parameters
[]
Preparation
["A valid doctorโ€™s prescription is required, except in cases of surgery, pregnancy, or travel abroad.", "Inform your healthcare provider of any anticoagulant therapy or bleeding disorders prior to sample collection."]
Indications
["Individuals with a family history of deafness", "Individuals with early-onset sensorineural hearing loss", "Couples planning a pregnancy wishing to understand carrier status"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 47997-3 ICD-10: H90.3
Clinical summary
This test evaluates over 100 genes associated with hereditary hearing loss using next-generation sequencing.
TEST-957
Dengue & Chikungunya Viruses PCR Qualitative Test

This test detects the presence of Dengue and Chikungunya viral RNA in patient samples.

Whole blood, serum, or CSF Next-day report 600.00 AED
View
View test specifications and preparation
What it measures
["Dengue virus RNA", "Chikungunya virus RNA"]
Parameters
[]
Preparation
[]
Indications
["Suspected Dengue infection", "Suspected Chikungunya infection", "Acute febrile illness", "Differentiation of viral causes in endemic regions", "Post-travel fever"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82145-0 ICD-10: A90, A92.0
Clinical summary
This test detects the presence of Dengue and Chikungunya viral RNA in patient samples.
TEST-940
Dengue 1-4 Viral Load Quantitative Test

This test quantitatively detects Dengue virus RNA in blood, serum, plasma, or CSF to confirm active infection and monitor viral load.

Whole Blood, Serum, Plasma, Cerebrospinal Fluid / CSF 24 hours (phone) / 36 hours (email) 550.00 AED
View
View test specifications and preparation
What it measures
["Dengue virus RNA", "Viral Load (quantitative)"]
Parameters
[{"name": "Dengue Virus RNA", "reference_range": "Not Detected"}]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected Dengue infection", "Monitoring disease progression", "Assessing risk of complications", "Early diagnosis during viremic phase"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48574-9 ICD-10: A90, A91
Clinical summary
This test quantitatively detects Dengue virus RNA in blood, serum, plasma, or CSF to confirm active infection and monitor viral load.
TEST-929
Dengue Virus and Chikungunya Virus (RNA Detection) Qualitative Test

This test detects the presence or absence of Dengue and Chikungunya viral RNA in a patient's blood sample.

Peripheral blood (serum or plasma) 24โ€“36 hours 550.00 AED
View
View test specifications and preparation
What it measures
["Dengue Virus RNA", "Chikungunya Virus RNA"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any anticoagulant therapy"]
Indications
["Suspected Dengue infection", "Suspected Chikungunya infection", "Acute febrile illness", "Differential diagnosis of mosquito-borne diseases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78036-8 ICD-10: A90, A92.0
Clinical summary
This test detects the presence or absence of Dengue and Chikungunya viral RNA in a patient's blood sample.
TEST-922
Dengue Virus and Chikungunya Virus Viral Load Quantitative Test

This test quantifies the amount of Dengue and Chikungunya virus RNA in patient samples to confirm active infection and monitor viral load.

Whole Blood, Serum, Plasma, Cerebrospinal Fluid (CSF) 24โ€“36 hours 600.00 AED
View
View test specifications and preparation
What it measures
["Dengue Virus RNA copies/mL", "Chikungunya Virus RNA copies/mL"]
Parameters
[{"name": "Dengue Virus RNA", "reference_range": "Undetectable"}, {"name": "Chikungunya Virus RNA", "reference_range": "Undetectable"}]
Preparation
["No specific fasting required", "Inform physician of all current medications"]
Indications
["Suspected Dengue infection", "Suspected Chikungunya infection", "Monitoring viral clearance", "Assessing treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 29677-8 ICD-10: A90, A92.0
Clinical summary
This test quantifies the amount of Dengue and Chikungunya virus RNA in patient samples to confirm active infection and monitor viral load.
TEST-976
Dengue Virus PCR Qualitative Test

This test detects the presence of Dengue virus RNA in patient samples.

Whole Blood (EDTA), Plasma, Serum, CSF Next Day (Sample by 11 AM) 650.00 AED
View
View test specifications and preparation
What it measures
["Dengue virus RNA", "Viral load (qualitative)"]
Parameters
[]
Preparation
["No special preparation required", "No fasting needed", "Continue regular diet and medications"]
Indications
["Suspected dengue cases", "Differential diagnosis of imported febrile illness", "Pre-travel screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 75362-9 ICD-10: A90
Clinical summary
This test detects the presence of Dengue virus RNA in patient samples.
TEST-208
DNA Library Preparation for Oxford Nanopore Technologies (ONT) Sequencing Test

This test prepares DNA for sequencing analysis using Oxford Nanopore Technology.

Extracted DNA or Whole Blood (Peripheral) 12 business days 4,500.00 AED
View
View test specifications and preparation
What it measures
["DNA library quality", "Library yield", "Fragment length distribution", "Adapter ligation efficiency"]
Parameters
[]
Preparation
[]
Indications
["Clinical genetic testing", "Research requiring long-read sequencing", "Molecular diagnostics", "Forensic analysis", "Sports eligibility testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94500-6 ICD-10: Z02.9, Z01.7, Z71.1
Clinical summary
This test prepares DNA for sequencing analysis using Oxford Nanopore Technology.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area